Lam KS - Search Results

1

Preclinical evaluation of cathepsin-degradable peptide linkers for radioimmunoconjugates.

DeNardo GL, DeNardo SJ, Peterson JJ, Miers LA, Lam KS, Hartmann-Siantar C, Lamborn KR. DeNardo GL, et al. Among authors: lam ks. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3865S-72S. Clin Cancer Res. 2003. PMID: 14506184

2

Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice.

DeNardo SJ, Yao Z, Lam KS, Song A, Burke PA, Mirick GR, Lamborn KR, O'Donnell RT, DeNardo GL. DeNardo SJ, et al. Among authors: lam ks. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3854S-64S. Clin Cancer Res. 2003. PMID: 14506183

3

Synthesis of hydrophilic and flexible linkers for peptide derivatization in solid phase.

Song A, Wang X, Zhang J, Marík J, Lebrilla CB, Lam KS. Song A, et al. Among authors: lam ks. Bioorg Med Chem Lett. 2004 Jan 5;14(1):161-5. doi: 10.1016/j.bmcl.2003.09.067. Bioorg Med Chem Lett. 2004. PMID: 14684320

4

Development of tissue plasminogen activator specific "on demand cleavable" (odc) linkers for radioimmunotherapy by screening one-bead-one-compound combinatorial peptide libraries.

Kumaresan PR, Natarajan A, Song A, Wang X, Liu R, DeNardo G, DeNardo S, Lam KS. Kumaresan PR, et al. Among authors: lam ks. Bioconjug Chem. 2007 Jan-Feb;18(1):175-82. doi: 10.1021/bc0602681. Bioconjug Chem. 2007. PMID: 17226971

5

Development of TNKase-specific cleavable peptide-linked radioimmunoconjugates for radioimmunotherapy.

Natarajan A, Kumaresan PR, Denardo SJ, Denardo GL, Mirick G, Lam KS. Natarajan A, et al. Among authors: lam ks. Bioorg Med Chem Lett. 2008 Sep 1;18(17):4802-5. doi: 10.1016/j.bmcl.2008.07.097. Epub 2008 Jul 30. Bioorg Med Chem Lett. 2008. PMID: 18701282

6

111In-LLP2A-DOTA Polyethylene Glycol-Targeting {alpha}4{beta}1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies.

Denardo SJ, Liu R, Albrecht H, Natarajan A, Sutcliffe JL, Anderson C, Peng L, Ferdani R, Cherry SR, Lam KS. Denardo SJ, et al. Among authors: lam ks. J Nucl Med. 2009 Apr;50(4):625-34. doi: 10.2967/jnumed.108.056903. Epub 2009 Mar 16. J Nucl Med. 2009. PMID: 19289419 Free article.

7

On-demand cleavable linkers for radioimmunotherapy.

Kumaresan PR, Luo J, Lam KS. Kumaresan PR, et al. Among authors: lam ks. Methods Mol Biol. 2009;539:191-211. doi: 10.1007/978-1-60327-003-8_11. Methods Mol Biol. 2009. PMID: 19377973

8

Halogenated benzimidazole carboxamides target integrin alpha4beta1 on T-cell and B-cell lymphomas.

Carpenter RD, Natarajan A, Lau EY, Andrei M, Solano DM, Lightstone FC, Denardo SJ, Lam KS, Kurth MJ. Carpenter RD, et al. Among authors: lam ks. Cancer Res. 2010 Jul 1;70(13):5448-56. doi: 10.1158/0008-5472.CAN-09-3736. Epub 2010 Jun 8. Cancer Res. 2010. PMID: 20530664 Free PMC article.

9

In-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphoma.

Zwingenberger AL, Kent MS, Liu R, Kukis DL, Wisner ER, DeNardo SJ, Taylor SL, Chen X, Lam KS. Zwingenberger AL, et al. Among authors: lam ks. PLoS One. 2012;7(4):e34404. doi: 10.1371/journal.pone.0034404. Epub 2012 Apr 24. PLoS One. 2012. PMID: 22545083 Free PMC article.

10

HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.

Duru N, Fan M, Candas D, Menaa C, Liu HC, Nantajit D, Wen Y, Xiao K, Eldridge A, Chromy BA, Li S, Spitz DR, Lam KS, Wicha MS, Li JJ. Duru N, et al. Among authors: lam ks. Clin Cancer Res. 2012 Dec 15;18(24):6634-47. doi: 10.1158/1078-0432.CCR-12-1436. Epub 2012 Oct 22. Clin Cancer Res. 2012. PMID: 23091114 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

983 results

Search Page

Filters